Use and adverse events of nitrous oxide/oxygen 50/50 mol/mol analgesic mixture: Assessment of cohort temporary authorisation results of SOL France pharmaceutical establishment;Utilisation et effets indesirables du mélange analgésique protoxyde d'azote/oxygène 50/50 (mole/mole): Évaluation du suivi de l'ATU de cohorte du laboratoire pharmaceutique SOL France

Journal de Pharmacie Clinique

Volumn 23, Issue 1, 2004, Pages 5-18

  Giraud, C ^a   Galene E ^a   Begue D ^b   Tixier, C ^c   Clement P ^c  

^a HÔPITAL LOUIS MOURIER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Laboratoire SOL France   (France)

Author keywords

Adverse event; Nitrous oxide; Oxygen; Temporary authorisation for prescribing medicine

Indexed keywords

ANALGESIC AGENT; LOCAL ANESTHETIC AGENT; NITROUS OXIDE; OXYGEN; PSYCHOTROPIC AGENT;

ADULT; AGITATION; ANALGESIA; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUSTRY; DRUG MARKETING; DRUG MIXTURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EUPHORIA; FEMALE; FRANCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINOR SURGERY; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; NIGHTMARE; PRESCRIPTION; PROSPECTIVE STUDY; RESPIRATION DEPRESSION; SIDE EFFECT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VERTIGO; VOMITING;

EID: 1942539134     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ahlborg G Jr, Axelsson G, Bodin L. Shift work, nitrous oxide exposure and subfertility among Swedish midwices. Int J Epidemiol 1996; 25: 783-90.
2. Amess JA, Burman JF, Rees GM, et al. Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet 1978; 2: 339-42.
3. Annequin D, Carbajal R, Chauvin P, et al. Fixed 50% nitrous oxide oxygen mixture for painful procedures: a French survey. Pediatrics 2000; 105: E47.
4. Annequin D, Dolfus C, Nicolas C, Murat I, Leverger G. Utilisation du protoxyde d'azote en hémato-oncologie pédiatrique lors de la pratique des ponctions lombaires et de myélogrammes. Ann Fr Anesth Réanim 1993; 12: R93.
5. Annequin D, Murat I. Bonnes pratiques pour l'utilisation antalgique du mélange équimolaire oxygène/protoxyde d'azote (MEOPA) chez l'enfant. Ann Fr Anesth Réanim 1998; 17: 160-3.
6. Arfeen Z, Armstrong PJ, Whifield A. The effects of Entonox and epidural analgesia on arterial oxygen saturation of women in labour. Anaesthesia 1994; 49: 32-4.
7. Axelsson G, Ahlborg G Jr, Bodin L. Shift work, nitrous oxide exposure, and spontaneous abortion among Swedish midwives. Occup Environ Med 1996; 53: 374-8.
8. Boutron C, Mathieu-Nolf M, Pety N, et al. Utilisations détournées du protoxyde d'azote. Ann Toxicol Anal 2000; 12: 211-2.
9. Carbajal R. Analgésie par mélange (50/50) de protoxyde d'azote/oxygène chez l'enfant. Arch Pediatr 1999; 6: 578-85.
10. Carbajal R, Hubert P, Treluyer JM, Jouvet P, Olivier-Martin M. Nitrous oxide and morphine in children with sickle cell crisis (letter). Lancet 1996; 347: 1621.
11. Carbajal R, Simon N. Sédation et analgésie chez l'enfant. Arch Pédiatr 1995; 2: 1089-96.
12. Carstoniu J, Levytam S, Norman P, Daley D, Katz J, Sandler AN. Nitrous oxide in early labour. Safety and analgesic efficacy assessed by a double-blind, placebo-controlled study. Anesthesiology 1994; 80: 30-5.
13. Castera L, Negre I, Gueroult N, et al. Nitrous oxide analgesia for intercostal liver biopsies: results of a prospective randomised trial. Hepatology 1996; 24: 1241.
14. Dolfus C, Annequin D, Adam M, et al. Analgésie par le protoxyde d'azote pour la pratique de gestes douloureux en oncohématologie pédiatrique. Ann Pédiatr 1995; 42: 115-21.
15. Dunn-Russel R, Adair SM, Sams DR, Russell CM, Barenie JT. Oxygen saturation and diffusion hypoxia in children following nitrous oxide sedation. Pediatr Dent 1993; 15: 88-92.
16. Einarsson S, Stenqvist O, Bengtsson A, Noren H, Bengtson JP. Gas kinetics during nitrous oxide analgesia for labour. Anaesthesia 1996; 51: 449-52.
17. 2? Ann Fr Anesth Réanim 1996; 15: R104.
18. Gall O, Annequin D, Benoit G, et al. Adverse events of premixed nitrous oxide and oxygen for procedural sedation in children. Lancet 2001; 358: 1514-5.
19. Gregory PR, Sullivan JA. Nitrous oxide compared with intravenous regional anesthesia in pediatric forearm fracture manipulation. J Pediatr Orthop 1996; 16: 187-91.
20. Griffin GC, Campbell VD, Jones R. Nitrous oxide-oxygen sedation for minor surgery. Experience in a pediatric setting. JAMA 1981; 245: 2411-3.
21. Henderson JM, Spence DG, Komocar LM, Bonn GE, Stenstrom RJ. Administration of nitrous oxide to pediatric patients provides analgesia for venous cannulation. Anesthesiology 1990; 72: 269-71.
22. Hennrikus WL, Simpson RB, Klingelberger CE, Reis MT. Self-administered nitrous oxide analgesia for pediatric fracture reductions. J Pediatric Orthop 1994; 14: 538-42.
23. Henry RJ, Jerrell RG. Ambient nitrous oxide levels during pediatric sedations. Pediatr Dent 1990; 12: 87-91.
24. Jenstrup M, Fruergaard KO, Mortensen CR. Pollution with nitrous oxide using laryngeal mask or face mask. Acta. Anaesthesiol Scand 1999; 43: 663-6.
25. King M, Coulter C, Boyle RS, et al. Neurotoxicity from overuse of nitrous oxide. Med J Aust 1995; 163: 50-1.
26. Koblin DD, Tomerson BW, Waldman FM, et al. Effect of nitrous oxide on folate and vitamin B12 metabolism in patients. Anesth Analg 1990; 71: 610-7.
27. Layzer RB. Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 1978; 2: 1227-30.
28. Le Gal V, Rosbicki S, Inghels Y, Urbina MA. Le mélange équimoléculaire protoxyde d'azote-oxygène sous autorisation temporaire d'utilisation (ATU). Pharm Hosp Fr 1999; 128: 107-12.
29. Lienhart A. Protoxyde d'azote. Editions Techniques - Encycl Méd Chir Paris 36279 A10, 6-1990: 13 p.
30. Louis-Ferdinand RT. Myelotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adv Drug React Toxicol Rev 1994; 13: 193-206.
31. Nunn JF. Clinical aspects of the interaction between nitrous oxide and vitamine B12. Br J Anaesth 1987; 59: 3-13.
32. Nunn JF, Sharer NM, Gorchein A, et al. Megaloblastic haemopoiesis after multiple short-term exposure to nitrous oxide. Lancet 1982; 1: 1379-81.
33. Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. Am J Neuroradiol 1998; 19: 894-6.
34. Pena BM, Krauss B. Adverse events of procedural sedation and analgesia in a pediatric emergency department. Ann Emerg Med 1999; 34: 483-91.
35. Petersen JK. Nitrous oxide analgesia in dental practice. Acta Anaesthesiol Scand 1994; 38: 773-4.
36. Rowland AS, Baird DD, Shore DL, Weinberg CR, Savitz DA, Wilcox AJ. Nitrous oxide and spontaneous abortion in female dental assistants. Am J Epidemiol 1995; 141: 531-8.
37. Rowland AS, Baird DD, Weinberg CR, et al. Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide. N Eng J Med 1992; 327: 993-7.
38. Scaberg DC, Yealy DM, Ilkhanipour K. Effect of nitrous oxide analgesia on pneumothorax. Acad Emerg Med 1995; 2: 287-92.
39. Sury MR, Hatch DJ, Deeley T, Dicks - Mireaux C, Chong WK. Development of a nurse-led sedation service for pediatric magnetic resonance imaging. Lancet 1999; 353: 1667-71.
40. Trojan J, Saunders BP, Woloshynowych M, Debinsky HS, Williams CB. Immediate recovery of psychomotor function after patient-administered nitrous oxide/oxygen inhalation for colonoscopy. Endoscopy 1997; 29: 17-22.
41. Tunstall ME. The use a fixed nitrous oxide and oxygen mixture from one cylinder. Lancet 1961; 2: 964.
42. Vetter TR. A comparison of EMLA cream versus nitrous oxide for pediatric venous cannulation. J Clin Anesth 1995; 7: 486-90.